[Consensus recommendations of the German Radiology Society (DRG), the German Cardiac Society (DGK) and the German Society for Pediatric Cardiology (DGPK) on the use of cardiac imaging with computed tomography and magnetic resonance imaging]. Achenbach S, Barkhausen J, Beer M, Beerbaum P, Dill T, Eichhorn J, Fratz S, Gutberlet M, Hoffmann M, Huber A, Hunold P, Klein C, Krombach G, Kreitner KF, Kuhne T, Lotz J, Maintz D, Mahrholdt H, Merkle Rofo 2012; 184(4): 345-368 ISSN 1438-9029 Impact factor: 2.758
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse G, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, T Europace 2012; 14(8): 1094-1103 ISSN 1099-5129 Impact factor: 1.980
Distribution of cardiac stem cells in the human heart. Arsalan M, Woitek F, Adams V, Linke A, Barten MJ, Dhein S, Walther T, Mohr FW, Garbade J ISRN Cardiol 2012; 2012: e483407 ISSN 2090-5580 Impact factor: 0.000
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, Schmidt A, Tessarek J, Vinck E, Schwartz LB J Vasc Surg 2012; 55(2): 390-398 ISSN 0741-5214 Impact factor: 3.153
[Epicardial approach during ablation of ventricular tachycardia in patients with ischaemic cardiomyopathy - utility and safety of the method]. Buchta P, Arya A, Hindricks G, Piorkowski C, Polonski L, Gasior M, Zembala M Kardiol Pol 2012; 70(3): 277-281 ISSN 0022-9032 Impact factor: 0.515
Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry. Buellesfeld L, Gerckens U, Erbel R, Zahn R, Linke A, Sievert H, Figulla HR, Kuck KH, Hauptmann KE, Hambrecht R, Richardt G, Naber C, Voehringer M, Mudra H, Senges J, Grube E J Invasive Cardiol 2012; 24(10): 531-536 ISSN 1042-3931 Impact factor: 1.841
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Ja Europace 2012; 14(4): 528-606 ISSN 1099-5129 Impact factor: 1.980
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Ja Heart Rhythm 2012; 9(4): 632-696 ISSN 1547-5271 Impact factor: 4.102
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Ja J Interv Card Electrophysiol 2012; 33(2): 171-257 ISSN 1383-875X Impact factor: 1.166
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P Europace 2012; 14(10): 1385-1413 ISSN 1099-5129 Impact factor: 1.980
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P Eur Heart J 2012; 33(21): 2719-2747 ISSN 0195-668X Impact factor: 10.478
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS N Engl J Med 2012; 367(17): 1587-1595 ISSN 0028-4793 Impact factor: 53.298
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobe N Engl J Med 2012; 367(11): 991-1001 ISSN 0028-4793 Impact factor: 53.298
Long-term efficacy of single procedure remote magnetic catheter navigation for ablation of ischemic ventricular tachycardia: a retrospective study. Dinov B, Schonbauer R, Wojdyla-Hordynska A, Braunschweig F, Richter S, Altmann D, Sommer P, Gaspar T, Bollmann A, Wetzel U, Rolf S, Piorkowski C, Hindricks G, Arya A J Cardiovasc Electrophysiol 2012; 23(5): 499-505 ISSN 1045-3873 Impact factor: 3.064
Echo didactic: visualization of the circumflex artery in the perioperative setting with transesophageal echocardiography. Ender J, Singh R, Nakahira J, Subramanian S, Thiele H, Mukherjee C Anesth Analg 2012; 115(1): 22-26 ISSN 0003-2999 Impact factor: 3.286
Right ventricular injury in ST-elevation myocardial infarction: risk stratification by visualization of wall motion, edema, and delayed-enhancement cardiac magnetic resonance. Grothoff M, Elpert C, Hoffmann J, Zachrau J, Lehmkuhl L, de Waha S, Desch S, Eitel I, Mende M, Thiele H, Gutberlet M Circ Cardiovasc Imaging 2012; 5(1): 60-68 ISSN 1941-9651 Impact factor: 5.941
Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J Circulation 2012; 126(18): 2261-2274 ISSN 0009-7322 Impact factor: 14.739
Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J Eur Heart J 2012; 33(23): 2917-2927 ISSN 0195-668X Impact factor: 10.478
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L Lancet Neurol 2012; 11(4): 315-322 ISSN 1474-4422 Impact factor: 23.462
Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial. Heeger CH, Jaquet K, Thiele H, Zulkarnaen Y, Cuneo A, Haller D, Kivelitz D, Schmidt T, Krause K, Metzner A, Schneider C, Kuck KH, Bergmann MW EuroIntervention 2012; 8(6): 732-742 ISSN 1774-024X Impact factor: 3.285
Effects of baseline P-wave duration and choice of atrial septal pacing site on shortening atrial activation time during pacing. Huo Y, Holmqvist F, Carlson J, Gaspar T, Arya A, Wetzel U, Hindricks G, Piorkowski C, Bollmann A, Platonov PG Europace 2012; 14(9): 1294-1301 ISSN 1099-5129 Impact factor: 1.980
Two-year outcomes after transcatheter or surgical aortic-valve replacement. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn N Engl J Med 2012; 366(18): 1686-1695 ISSN 0028-4793 Impact factor: 53.298
A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jais P, Nakagawa H, Lambert H, Shah DC Heart Rhythm 2012; 9(1): 18-23 ISSN 1547-5271 Impact factor: 4.102
Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. Lahtela H, Rubboli A, Schlitt A, Karjalainen PP, Niemela M, Vikman S, Puurunen M, Weber M, Valencia J, Biancari F, Lip GY, Airaksinen KE Circ J 2012; 76(6): 1363-1368 ISSN 1346-9843 Impact factor: 3.766
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Cao AY, Jaff MR J Endovasc Ther 2012; 19(1): 1-9 ISSN 1526-6028 Impact factor: 2.856
Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature. Lammer J, Scheinert D, Vermassen F, Koppensteiner R, Hausegger KA, Schroe H, Menon RM, Schwartz LB J Vasc Surg 2012; 55(2): 400-405 ISSN 0741-5214 Impact factor: 3.153
Chemerin as a mediator between obesity and vascular inflammation in children. Landgraf K, Friebe D, Ullrich T, Kratzsch J, Dittrich K, Herberth G, Adams V, Kiess W, Erbs S, Korner A J Clin Endocrinol Metab 2012; 97(4): 556-564 ISSN 0021-972X Impact factor: 5.967
Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. Lauten A, Zahn R, Horack M, Sievert H, Linke A, Ferrari M, Harnath A, Grube E, Gerckens U, Kuck KH, Sack S, Senges J, Figulla HR JACC Cardiovasc Interv 2012; 5(5): 552-559 ISSN 1936-8798 Impact factor: 6.800
Dynamic CT angiography after abdominal aortic endovascular aneurysm repair: differences in contrast agent dynamics in the aorta and endoleaks-preliminary results. Lehmkuhl L, Andres C, Lucke C, Foldyna B, Grothoff M, Scheinert D, Nitzsche S, Gutberlet M J Vasc Interv Radiol 2012; 23(6): 744-750 ISSN 1051-0443 Impact factor: 2.075
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses N Engl J Med 2012; 366(18): 1696-1704 ISSN 0028-4793 Impact factor: 53.298
Rivaroxaban in patients with a recent acute coronary syndrome. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM N Engl J Med 2012; 366(1): 9-19 ISSN 0028-4793 Impact factor: 53.298
Predictors of long-term success after catheter ablation of atriofascicular accessory pathways. Monnig G, Wasmer K, Milberg P, Schulz P, Kobe J, Zellerhoff S, Kochhauser S, Pott C, Hindricks G, Borggrefe M, Breithardt G, Eckardt L Heart Rhythm 2012; 9(5): 704-708 ISSN 1547-5271 Impact factor: 4.102
Long-term importance of right ventricular outflow tract patch function in patients with pulmonary regurgitation. Puranik R, Tsang V, Lurz P, Muthurangu V, Offen S, Frigiola A, Norman W, Walker F, Bonhoeffer P, Taylor AM J Thorac Cardiovasc Surg 2012; 143(5): 1103-1107 ISSN 0022-5223 Impact factor: 3.406
Impact of pulmonary valve replacement in tetralogy of Fallot with pulmonary regurgitation: a comparison of intervention and nonintervention. Quail MA, Frigiola A, Giardini A, Muthurangu V, Hughes M, Lurz P, Khambadkone S, Deanfield JE, Tsang V, Taylor AM Ann Thorac Surg 2012; 94(5): 1619-1626 ISSN 0003-4975 Impact factor: 3.741
Venice chart international consensus document on atrial fibrillation ablation: 2011 update. Raviele A, Natale A, Calkins H, Camm JA, Cappato R, Ann Chen S, Connolly SJ, Damiano R Jr, DE Ponti R, Edgerton JR, Haissaguerre M, Hindricks G, Ho SY, Jalife J, Kirchhof P, Kottkamp H, Kuck KH, March J Cardiovasc Electrophysiol 2012; 23(8): 890-923 ISSN 1045-3873 Impact factor: 3.064
The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jais P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH Heart Rhythm 2012; 9(11): 1789-1795 ISSN 1547-5271 Impact factor: 4.102
A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia. Richter S, Gebauer R, Hindricks G, Brugada P J Cardiovasc Electrophysiol 2012; 23(5): 560 ISSN 1045-3873 Impact factor: 3.064
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wohrle J J Am Coll Cardiol 2012; 59(15): 1377-1382 ISSN 0735-1097 Impact factor: 14.156
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. Sinning JM, Horack M, Grube E, Gerckens U, Erbel R, Eggebrecht H, Zahn R, Linke A, Sievert H, Figulla HR, Kuck KH, Hauptmann KE, Hoffmann E, Hambrecht R, Richardt G, Sack S, Senges J, Nickenig G, Wern Am Heart J 2012; 164(1): 102-110 ISSN 0002-8703 Impact factor: 4.651
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia. Springer J, Tschirner A, Hartman K, Palus S, Wirth EK, Ruis SB, Moller N, von Haehling S, Argiles JM, Kohrle J, Adams V, Anker SD, Doehner W Int J Cancer 2012; 131(9): 2187-2196 ISSN 0020-7136 Impact factor: 5.444
Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF-rationale and design. Stoylen A, Conraads V, Halle M, Linke A, Prescott E, Ellingsen O Eur J Prev Cardiol 2012; 19(4): 813-821 ISSN 2047-4873 Impact factor: 0.000
Feasibility of the Engagerâ„¢ aortic transcatheter valve system using a flexible over-the-wire design. Sundermann SH, Grunenfelder J, Corti R, Rastan AJ, Linke A, Lange R, Falk V, Bleiziffer S Eur J Cardiothorac Surg 2012; 42(4): 48-52 ISSN 1010-7940 Impact factor: 2.550
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. Trenk D, Stone GW, Gawaz M, Kastrati A, Angiolillo DJ, Müller U, Richardt G, Jakubowski JA, Neumann FJ J Am Coll Cardiol 2012; 59(24): 2159-2164 ISSN 0735-1097 Impact factor: 14.156
Transapical aortic valve implantation at 3 years. Walther T, Kempfert J, Rastan A, Borger MA, Linke A, Ender J, Schuler G, Mohr FW J Thorac Cardiovasc Surg 2012; 143(2): 326-331 ISSN 0022-5223 Impact factor: 3.406
Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis. Werner M, Scheinert D, Henn M, Scheinert S, Braunlich S, Bausback Y, Friedenberger J, Schuster J, Hertting K, Piorkowski M, Rosner C, Schmidt A, Ulrich M, Gutberlet M J Endovasc Ther 2012; 19(4): 467-475 ISSN 1526-6028 Impact factor: 2.856
